Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptors - Wikidata - awgldk - TriplyDB

Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptors

Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptors

http://www.wikidata.org/entity/Q30497637

about

Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer's disease Antidiabetic Effect of Galantamine: Novel Effect for a Known Centrally Acting Drug Checkpoints to the Brain: Directing Myeloid Cell Migration to the Central Nervous System Galantamine slows down plaque formation and behavioral decline in the 5XFAD mouse model of Alzheimer's disease.A novel cell line from spontaneously immortalized murine microglia.Astrocytic and microglial nicotinic acetylcholine receptors: an overlooked issue in Alzheimer's disease.Acetylcholinesterase inhibitor modifications: a promising strategy to delay the progression of Alzheimer's disease.Microglial Amyloid-β1-40 Phagocytosis Dysfunction Is Caused by High-Mobility Group Box Protein-1: Implications for the Pathological Progression of Alzheimer's Disease.Molecular Docking Study on Galantamine Derivatives as Cholinesterase Inhibitors.A comparative review of cell culture systems for the study of microglial biology in Alzheimer's disease.Galantamine effect on tularemia pathogenesis in a BALB/c mouse model.The mixed-lineage kinase 3 inhibitor URMC-099 facilitates microglial amyloid-β degradation Age-Related Decline in Brain and Hepatic Clearance of Amyloid-Beta is Rectified by the Cholinesterase Inhibitors Donepezil and Rivastigmine in Rats.Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's disease.Calcium ion influx in microglial cells: physiological and therapeutic significance.Inhibitors of acetylcholinesterase and butyrylcholinesterase meet immunity.Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases.Innate immunity in Alzheimer's disease.Nasal Application of the Galantamine Pro-drug Memogain Slows Down Plaque Deposition and Ameliorates Behavior in 5X Familial Alzheimer's Disease Mice.The Gut Microbiota and Alzheimer's Disease.Galantamine-loaded solid-lipid nanoparticles for enhanced brain delivery: preparation, characterization, in vitro and in vivo evaluations.Animal Models of Alzheimer's Disease: Utilization of Transgenic Alzheimer's Disease Models in Studies of Amyloid Beta Clearance.Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.Donepezil suppresses intracellular Ca2+ mobilization through the PI3K pathway in rodent microglia.β-Amyloid and the Pathomechanisms of Alzheimer's Disease: A Comprehensive View.Nicotinic acetylcholine receptors mediate donepezil-induced oligodendrocyte differentiation.Docking-based design and synthesis of galantamine-camphane hybrids as inhibitors of acetylcholinesterase.Activation of spinal alpha-7 nicotinic acetylcholine receptor shortens the duration of remifentanil-induced postoperative hyperalgesia by upregulating KCC2 in the spinal dorsal horn in rats.Effects of sub-chronic donepezil on brain Abeta and cognition in a mouse model of Alzheimer's disease.Urinary Incontinence in Alzheimer's Disease.Disruption of White Matter Integrity by Chronic Cerebral Hypoperfusion in Alzheimer's Disease Mouse Model.Galantamine anti-colitic effect: Role of alpha-7 nicotinic acetylcholine receptor in modulating Jak/STAT3, NF-κB/HMGB1/RAGE and p-AKT/Bcl-2 pathways.Galantamine Response Associates with Agitation and the Prefrontal Cortex in Patients with Alzheimer's Disease.Formulation and evaluation of galantamine gel as drug reservoir in transdermal patch delivery system.Strong Impact of Chronic Cerebral Hypoperfusion on Neurovascular Unit, Cerebrovascular Remodeling, and Neurovascular Trophic Coupling in Alzheimer's Disease Model Mouse.URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer's disease.Galantamine Derivatives as Acetylcholinesterase Inhibitors: Docking, Design, Synthesis, and Inhibitory Activity Docking-based Design of Galantamine Derivatives with Dual-site Binding to Acetylcholinesterase Importance of GPCR-Mediated Microglial Activation in Alzheimer's Disease

P2860

Q26765419-EA5BDE60-C226-453F-9E0F-8F69462E20D9 Q27025207-BAEBCCCA-9F25-4854-B4B8-54FC76F17A4B Q27301094-74200991-DA38-4A98-8E94-6EE6C83313D4 Q28066906-5097EB16-E1C2-4DCC-BE40-4C178F7A7A82 Q28540060-3DA31447-F2BF-4C89-B457-F7510C619524 Q34073229-B5DCE7D0-779D-4E41-B1EE-5E4DB5981925 Q34529680-8D193A69-565F-4EBF-94AE-70F6EA760CE4 Q35169922-447A7EE3-BA96-43A0-9D7F-F32104D45B97 Q35975429-B1CEAC5C-4453-4ABE-A381-C14ABDDA375C Q36094892-EC29D994-4C5C-4199-9F27-F1905E60A426 Q36125335-EE2D5B7B-1452-405B-A114-9133A2F59695 Q36777164-CE842DF3-19B4-4B42-A16F-81614D3AD066 Q37085168-BD995651-444C-4F34-B3DC-03FFC3AB72E2 Q37596042-4B73A6CF-ECAB-4E0F-B26B-1567B87615AF Q37607844-34C3116A-FF90-4BDB-9D35-3C5A089DFAF0 Q38182045-5957DD83-C5D8-4A06-A0C8-6BD8C6B68323 Q38217301-0B582286-B645-407D-A787-BB47D06DEFDC Q38322767-1A68BF8C-1A6F-4C1F-9A92-6DAC3FD4284B Q38358574-97DA2B68-D24D-4A97-AE99-74BF31121099 Q39193474-C67D1C75-539B-41A5-B53B-D23FE5FAE54F Q39217126-BF3A046F-9C87-4665-BD90-FEEAF2B165C2 Q40502575-0CF0284A-2123-4213-A0E9-0C8CD590085A Q42119910-87D7BC51-DA24-4EAB-A56A-2BB1F5B8891F Q46463474-B2BA7D47-12A5-4A93-9A19-CCA960497B39 Q47107415-47A4EBAD-B49D-4620-94CD-F8C9F6A3DD53 Q47672665-21127EB0-9980-4618-8B9F-06F867A8F6A8 Q47910897-727BFA6B-00DD-430E-952A-1C7CF9C74DC2 Q48231536-44661D29-D39B-4490-85F4-9864290822EB Q50715192-3F1F391E-224C-4C0E-A742-9930EC6FE180 Q50738123-351CFC39-4F12-45EE-8A2C-D153C327C365 Q51329621-E590CEC8-8365-4A09-A055-BF2B4086DE19 Q52140079-701A431D-3632-4053-8946-21762CBA7D74 Q52639338-B7806B56-4CD6-46FB-9057-6B4D1EA58F3B Q52951273-D2D37767-B40D-4ECD-8513-0490F80956C9 Q53363354-954839A3-D594-40EC-A424-B7AF4E50F34F Q53376342-C2A99941-68EF-44FA-A4D3-E0D6E5B0A582 Q54979695-7195B68D-69D2-4BE2-844E-707CD0A7CDA6 Q57021427-F1ACAB29-5E14-43CD-8736-39BFA5D58052 Q57021449-7CB92034-81AA-4403-A94A-424FD1BB7C62 Q58729326-43B0D9E3-86FF-48D4-A246-941B6EAE9F8A

P2860

Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptors

http://www.wikidata.org/entity/Q30497637

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Galantamine-induced amyloid-{b ...... otinic acetylcholine receptors

@ast

Galantamine-induced amyloid-{b ...... otinic acetylcholine receptors

@en

type

label

Galantamine-induced amyloid-{b ...... otinic acetylcholine receptors

@ast

Galantamine-induced amyloid-{b ...... otinic acetylcholine receptors

@en

prefLabel

Galantamine-induced amyloid-{b ...... otinic acetylcholine receptors

@ast

Galantamine-induced amyloid-{b ...... otinic acetylcholine receptors

@en

P1433

Q30497637-D8E7FD30-44E6-4A9D-85CD-D19CA3E7824C

P1476

Q30497637-BA75456E-0E2B-40AA-BFF3-407A4184627D

P2093

Q30497637-0C1BD360-EECA-4794-9F6B-3FF96EA74136

Q30497637-1CCDB8B0-5935-43AB-BF87-92C8AD2AFEB5

Q30497637-5C635B98-7DB4-4EBA-8127-851B55966480

Q30497637-7A15C5D6-B758-49B8-8971-719BEEE38308

Q30497637-94980318-AE29-4582-8A03-D58853B4BA4E

Q30497637-94A40546-FE6D-477F-A21D-C4D3B178B55D

Q30497637-97B6B3E5-AE1C-42E6-AF03-389CDAA3F4D7

Q30497637-D8072B27-B5D9-4DE9-8BE2-D727658D9F04

Q30497637-F0A666E1-27DE-4A6D-B1A5-89A9A349F3C9

Q30497637-FA82DBA4-688C-4B7D-B640-CB0B23FD21DD

P2860

Q30497637-034A7535-1CF2-4B43-8613-E5950839D643

Q30497637-04EC6D40-455A-4829-9E7A-AB65F0227A53

Q30497637-059034A7-5040-4B8F-BC02-1317850B5633

Q30497637-06DAA9E2-7F23-4922-9949-94A232A78863

Q30497637-07569437-990A-4E1F-AAC4-00C4DD6574E8

Q30497637-09F6B92E-2ED0-4055-B770-FC87ED877B4E

Q30497637-11390E12-0832-45B1-A456-79CF30E2E17D

Q30497637-11591EC2-D8E7-4F02-82F4-DA49E90996D1

Q30497637-158120F4-6028-41B4-B580-EBCA2CAFCC9D

Q30497637-2257C28A-5D6D-4F9C-B72D-CCBD7FA5B908

P304

Q30497637-68AEBD48-B98D-4FFE-B777-FB6940ACAD22

P31

Q30497637-E4911D61-A1F0-4682-970C-73F16DE02A0F

P356

Q30497637-ECD9473D-C473-41AA-BCC0-EC21BA6F85C3

P407

Q30497637-FD7C2ADD-C005-4F8D-93EC-07DF2AB8E14D

P433

Q30497637-85A8ED99-5CF4-4665-AD84-245301E9E8C6

P478

Q30497637-C7565DF8-240A-4F00-B91A-9CA4ABD1BB62

P577

Q30497637-88338094-7004-4C13-B565-16D6D797803E

P5875

Q30497637-1544DFA4-F730-4029-AECA-FD39DBE1E70D

P698

Q30497637-26D8298F-1DAD-4FFE-BBEE-3813C87CB4C4

P921

Q30497637-9E596C90-20B8-4A25-9E33-5905E264D696

Q30497637-D2201160-99DE-4135-B56D-0EA937A03A5F

P932

Q30497637-552C95F1-2C26-423E-A314-00DF43839DAE

P356

JBC.M110.142356

P1433

Journal of Biological Chemistry

P1476

Galantamine-induced amyloid-{b ...... otinic acetylcholine receptors

@en

P2093

Alfred Maelicke

http://www.w3.org/2001/XMLSchema#string

Hidekazu Tomimoto

http://www.w3.org/2001/XMLSchema#string

Kazuyuki Takata

http://www.w3.org/2001/XMLSchema#string

Maki Terada

http://www.w3.org/2001/XMLSchema#string

Mana Saeki

http://www.w3.org/2001/XMLSchema#string

Risa Kitamura

http://www.w3.org/2001/XMLSchema#string

Sachiko Kagitani

http://www.w3.org/2001/XMLSchema#string

Shun Shimohama

http://www.w3.org/2001/XMLSchema#string

Takashi Taniguchi

http://www.w3.org/2001/XMLSchema#string

Yasuhiro Fujikawa

http://www.w3.org/2001/XMLSchema#string

P2860

WAVE, a novel WASP-family protein involved in actin reorganization induced by Rac

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

Rho GTPases and the actin cytoskeleton

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase

alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Involvement of Wiskott-Aldrich syndrome protein family verprolin-homologous protein (WAVE) and Rac1 in the phagocytosis of amyloid-beta(1-42) in rat microglia.

P304

40180-40191

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M110.142356

http://www.w3.org/2001/XMLSchema#string

P407

P433

51

http://www.w3.org/2001/XMLSchema#string

P478

285

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47429086

http://www.w3.org/2001/XMLSchema#string

P698

20947502

http://www.w3.org/2001/XMLSchema#string

P921

P932

3001000

http://www.w3.org/2001/XMLSchema#string